TriMark Publications, July 2011, Pages: 214
revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of cancer.
This report analyzes the size and growth of the molecular diagnostics market in its
Jain PharmaBiotech, May 2012, Pages: 1037
technologies, applications and geographical regions. Forecasts are made up to 2021. A major portion of the molecular diagnostic market can be attributed to advances in genomics and proteomics. Biochip and
Espicom Business Intelligence Ltd, Aug 2011, Pages: 382
required to increase survival and delay disease progression.
Unique breast cancermarket share, sales forecasts by launched and Phase III products to 2017
A comprehensive and critical examination and
Datamonitor, July 2010, Pages: 111
Japan, plus a rest of world snapshot
-Antihormonal therapy sales forecasts for brands and generics from 2009 to 2019
-Assessment of the leading cancer brands and drug classes to identify key success
TriMark Publications, July 2011, Pages: 335
, screening, prognostic, monitoring, pharmacogenomic and theranostic--from their basic principles to their applications;
3) discovering feasible market opportunities by identifying high-growth applications in
Venture Planning Group, Oct 2010, Pages: 1200
worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field.Anticipated technological breakthroughs will create numerous opportunities for determining genetic
Life Science Intelligence, Inc., Jan 2011
monitoring device
- Advanced, portable and easy-to-use noninvasive devices for the assessment of traumatic brain injury (TBI) at the point of care
- Interventional cardiology devices for chronic total
Markets and Markets, Sep 2009, Pages: 256
tools are being developed to increase the discovery speed of cancer biomarkers. The use of proteomics in biomarker testing and identification has in turn boosted the services for the biomarkers. Market
Espicom Business Intelligence Ltd, March 2009, Pages: 206
market will be more diverse, with 12 companies taking more than 1% market share in 2014, as opposed to 6 in 2007.
Vaccines
The benefits of lung cancer vaccines remain significant, but without launch and
Venture Planning Group, June 2011, Pages: 1200
of the genetic basis of the disease. During the next ten years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological
TriMark Publications, Feb 2012, Pages: 460
subjective commentary of the company's market position. Detailed tables and charts with sales forecastsandmarket data are also included.
Keywords: point of care, POC, point of care testing, POCT, diagnostic
TriMark Publications, Dec 2004, Pages: 222
145
8.1.3 Analyses of the Current Market Conditions, Competition and Product Mix 146
8.1.4 New Approaches to the Glucose Data Management Marketplace 147
8.1.5 How Each Company is Losing/Gaining
